Dr. Jane Grogan is Executive Vice President (E.V.P.) and Head of Research at Biogen. Dr. Grogan joined Biogen in 2023, bringing nearly two decades of experience in leading biotech research, including fifteen years with Genentech. Dr. Grogan most recently served as Chief Scientific Officer at Graphite Bio and at ArsenalBio, both cell- and gene-therapy companies. During her time at Genentech, she served in several increasingly senior roles across Immunology and Immuno-oncology, covering research strategies and drug development across RA, Lupus, MS, IBD, and Cancer. Preceding her career in the Biotechnology Industry, Dr. Grogan completed her Ph.D. in immunology at Leiden University and her B.Sc. in Biochemistry and Pharmacology at the University of Melbourne.
Dr. Jane Grogan is Executive Vice President (E.V.P.) and Head of Research at Biogen. Dr. Grogan joined Biogen in 2023, bringing nearly two decades of experience in leading biotech research, including fifteen years with Genentech. Dr. Grogan most recently served as Chief Scientific Officer at Graphite Bio and at ArsenalBio, both cell- and gene-therapy companies. During her time at Genentech, she served in several increasingly senior roles across Immunology and Immuno-oncology, covering research strategies and drug development across RA, Lupus, MS, IBD, and Cancer. Preceding her career in the Biotechnology Industry, Dr. Grogan completed her Ph.D. in immunology at Leiden University and her B.Sc. in Biochemistry and Pharmacology at the University of Melbourne.